Rapid detection of infectious viral particles by cluster induced exhaustive reaction
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
批准号:
10443877
负责人:
Jun Wang
金额:
$23.59万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-02 至 2024-06-30
关键词:
2019-nCoVAddressAerosolsAffinityAirAmericanAntibodiesAntigensBindingBiological AssayBloodBreathingCOVID-19COVID-19 detectionCOVID-19 pandemicCessation of lifeCommunicable DiseasesCommunitiesCoronavirusCoughingDepositionDetectionDevicesDiagnosisDiagnostic EquipmentEnsureEnvironmentEnzyme-Linked Immunosorbent AssayEpitopesEvaluationExhalationExhibitsGoalsGoldGovernmentHealthHorseradish PeroxidaseHospitalsHumanImmigrationImmunoglobulin GImmunoglobulin MIndividualInfectionLengthLifeLiftingLocationMeasuresMethodsNebulizerPaperPatientsPersonsPoliciesPolymerase Chain ReactionPopulationRapid diagnosticsReactionRecording of previous eventsResourcesSafetySamplingSensitivity and SpecificitySignal TransductionSiteSneezingSocietiesSpecificitySpeedSpottingsSurfaceSymptomsTannic AcidTechniquesTechnologyTestingTimeVariantViralVirionVirusVisualizationbaseclinical diagnosiscostdesigndetection limitdiagnostic technologiesdiagnostic toolexhaustionfluinfluenzavirusinnovationinstrumentmultiplex detectionnanoparticlepandemic diseaseparticlepathogenrapid detectionrapid testreconstitutionrespiratory aerosolrespiratory virusscreeningsensortransmission processwastingyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
The COVID-19 pandemic has posed enormous challenges to health, economy, environment and immigration in
the US. Enhancement of diagnosis capacity together with restriction policies has been widely implemented to
contain the virus spreading. However, there are still over 200,000 deaths and half million hospitalized in the US
alone. The virus, Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), is highly contagious while
early infection particularly in young adults often exhibits no symptoms when they are actively transmitting viruses
in the community through speaking and breathing. These two transmission approaches normally emit much
lower number of virus particles in aerosols than coughing and sneezing, and thus are difficult to detect. Despite
many types of diagnostic tools available, current on-site diagnostic technologies do not have the sufficient
sensitivity and speed to detect low number of virus particles in aerosols emitted by infected people. The gold
standard method, polymerase chain reaction (PCR), and its variants are only ultrasensitive in the lab setting to
detect low copy number of viruses. Emitted aerosols are attractive target for clinical diagnosis because sampling
is not invasive, and the detection results directly determine whether a person is spreading viruses or not. To
address the above challenge, we will develop a rapid diagnostic technology based on cluster induced exhaustive
reaction (CIER) with the few virus sensitivity and disposable device with the cost of pennies, so that this kind of
paper device can be used frequently anywhere to identify an infectious individual immediately before he/she
further spreads SARS-CoV-2 to the community. CIER enables theoretically unlimited amplification of signal while
maintaining high specificity, and thus is highly applicable to detect SARS-CoV-2 particles where only the compact
cluster of antigens can trigger the CIER sensor. Two specific aims are proposed: (1) Construct CIER sensor by
assembling antibodies, spacer and HRP moieties, and optimize CIER’s design for detecting of SARS-CoV-2
virus particles with ultra-high sensitivity, and (2) Rapidly quantify SARS-CoV-2 virus particles in breath and on
surface for POC diagnosis, and distinguish influenza virus from SARS-CoV-2 by multiplexed detection. This
transformative diagnostic technology will possess ultrahigh sensitivity and specificity to detect SARS-CoV-2
viruses in exhaled air while in low cost and simple to use by any person. The use of CIER paper will not only
immediately identify virus spreading people, but also save huge waste of resources to contain pandemic by a
small percentage of contagious individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Striatal ensemble plasticity in alcohol use disorder
-
批准号:10734890
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2023
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10457835
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
-
批准号:10343115
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Repurposing of Maraviroc for the treatment of neuropathic pain
-
批准号:10586296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10364861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
NanoDiagnotic Technology I-Corps Training
-
批准号:10541690
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10543633
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10693823
-
项目类别:
-
资助金额:$73.01万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10653682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10191875
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10282122
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides
-
批准号:10255622
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Single-Cell Functional Proteomics Study of Neurodegeneration in Alzheimer's Disease
-
批准号:10191268
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10599264
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10513411
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
-
批准号:9740018
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10190746
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10543627
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10454230
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10693144
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
海外基金